S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer
Pancreatic cancer (PC) is a highly fatal and aggressive disease with its incidence and mortality quite discouraging. It is of great significance to construct an effective prognostic signature of PC and find the novel biomarker for the optimization of the clinical decision-making. Due to the crucial...
Guardado en:
Autores principales: | Yuan Chen, Chengcheng Wang, Jianlu Song, Ruiyuan Xu, Rexiati Ruze, Yupei Zhao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e60081513ee34c9ebe66633f2a913c9b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma
por: Jiannan Yao, et al.
Publicado: (2021) -
DNA Methylation Modification Map to Predict Tumor Molecular Subtypes and Efficacy of Immunotherapy in Bladder Cancer
por: Fangdie Ye, et al.
Publicado: (2021) -
Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma
por: Yumei Fan, et al.
Publicado: (2021) -
Potential application of protease isolated from Pseudomonas aeruginosa PD100
por: Najafi,Mohsen Fathi, et al.
Publicado: (2005) -
Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
por: Pingfei Tang, et al.
Publicado: (2021)